Standard first-line chemotherapy with or without nintedanib for advanced ovarian cancer (AGO-OVAR 12): a randomised, double-blind, placebo-controlled phase 3 trial

Erstveröffentlichung

2016

Authors

du Bois, Andreas

Kristensen, Gunnar

Ray-Coquard, Isabelle

Reuss, Alexander

Pignata, Sandro

et al.

Wissenschaftlicher Artikel

Published in

Lancet Oncology ; 17 (2016), 1. - S. 78-89. - ISSN 1470-2045. - eISSN 1474-5488

Link to publication

https://dx.doi.org/10.1016/S1470-2045(15)00366-6

Institutions

UKU. Klinik für Frauenheilkunde und Geburtshilfe

Subject headings

[DDC subject group]: DDC 610 / Medicine & health

---

Metadata

Show full item record